Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2005

Bienz Marianne, Ludwig Madleina, Leibundgut Elisabeth Oppliger, Mueller Beatrice U, Ratschiller Daniel, Solenthaler Max, Fey Martin F, Pabst Thomas

Abstract excerpt

PURPOSE: The recognition of a number of leukemia-specific cytogenetic abnormalities and their role as independent prognostic factors have provided considerable insights into leukemia pathogenesis and have paved the way to adopt risk-adapted treatment. However, approximately 50% of newly diagnosed acute myeloid leukemia (AML) have a normal karyotype. There has therefore been much interest in identifying molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to CCAAT-Enhancer-Binding Protein-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Immunophenotyping

Share to Karyotyping

Share to Leukemia, Myeloid

Share to Receptor Protein-Tyrosine Kinases

Share to Survival Analysis

Source

Identifiers

PMID: 15746041
DOI: 10.1158/1078-0432.CCR-04-1552

Genes

BAALC
FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.PMID 15746041Read ↗

Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.Semantic proximity Read ↗

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsSemantic proximity Read ↗

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patientsSemantic proximity Read ↗

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.Semantic proximity Read ↗

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.Semantic proximity Read ↗

BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemiaSemantic proximity Read ↗

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Semantic proximity Read ↗

CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.Semantic proximity Read ↗

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.Semantic proximity Read ↗

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogeneticsSemantic proximity Read ↗

Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Classification and risk assessment in AML: integrating cytogenetics and molecular profilingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.